Literature DB >> 938286

Scleral tuberculosis.

S E Bloomfield, B Mondino, G F Gray.   

Abstract

A case of scleral tuberculosis was successfully treated by combined systemic and local therapy. The importance of biopsy for early diagnosis and initiation of curative treatment is stressed.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 938286     DOI： 10.1001/archopht.1976.03910030482009

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


  7 in total

1.  The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area.

Authors:  Jolly Tsui; Mary Ho; Grace Lui; Timothy Li; Lijia Chen; Lawrence Iu; Marten Brelen; Alvin L Young
Journal:  Int Ophthalmol       Date:  2021-05-26       Impact factor: 2.031

Review 2.  Ocular Tuberculosis.

Authors:  Daniel M Albert; Meisha L Raven
Journal:  Microbiol Spectr       Date:  2016-11

Review 3.  Tubercular posterior scleritis: A case report and review of literature.

Authors:  Aanchal Mehta Agarwal; Parthopratim Dutta Majumder
Journal:  Indian J Ophthalmol       Date:  2019-08       Impact factor: 1.848

4.  An OCT Study of Anterior Nodular Episcleritis and Scleritis.

Authors:  Christos Christakopoulos
Journal:  Case Rep Ophthalmol Med       Date:  2017-02-28

5.  Tuberculous scleritis in a young Asian Indian girl-a case presentation and literature review.

Authors:  Lagan Paul; Manisha Agarwal; Shalini Singh; Prashant Katre; Aman Sumeet Arora
Journal:  J Ophthalmic Inflamm Infect       Date:  2019-12-23

Review 6.  Orbital and external ocular manifestations of Mycobacterium tuberculosis: A review of the literature.

Authors:  Lauren A Dalvin; Wendy M Smith
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2015-11-27

Review 7.  Scleritis: Differentiating infectious from non-infectious entities.

Authors:  Somasheila I Murthy; Swapnali Sabhapandit; S Balamurugan; Pranesh Subramaniam; Maite Sainz-de-la-Maza; Manisha Agarwal; Carlos Parvesio
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.